Profil
Benoit Pinteur is the founder and currently holds the position of Chief Scientific Officer at Brenus Pharma SAS, which is founded in 2020.
Postes actifs de Benoit Pinteur
| Sociétés | Poste | Début |
|---|---|---|
Brenus Pharma SAS
 Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Founder | 20/02/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Commercial Services |
